查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916927

非处方眼药水和润滑剂市场按产品类型、储存系统、剂型、活性成分、适应症、通路和最终用户划分－2026-2032年全球预测

OTC Eye Drops & Lubricants Drugs Market by Product Type, Preservation System, Dosage Form, Active Ingredient, Indication, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，非处方眼药水和润滑剂市场价值将达到 234 亿美元，到 2026 年将成长至 250.8 亿美元，到 2032 年将达到 381.7 亿美元，复合年增长率为 7.23%。

关键市场统计数据
基准年 2025 234亿美元
预计年份：2026年 250.8亿美元
预测年份 2032 381.7亿美元
复合年增长率 (%) 7.23%

本书以简洁权威的语言，概述了正在重新定义非处方眼药水和眼部润滑剂策略的临床、商业性和消费者趋势。

非处方眼药水和眼部润滑剂类别处于消费者健康、眼科护理和零售药房管道的关键交汇点，其增长动力源于症状的日益增多、意识提升以及产品创新。慢性眼表疾病和间歇性刺激症状促使人们寻求兼具疗效、耐受性和便利性的便利治疗方法。同时，配方科学和防腐技术的进步也提升了人们对更温和、更持久缓解方案的期望，迫使製造商重新评估产品系列策略和生产投资。

配方创新、对防腐剂的严格审查以及不断变化的通路如何推动非处方眼科润滑剂的开发和商业化发生根本性转变

过去几年，随着配方科学、通路和监管的融合，眼科润滑剂市场发生了变革性变化，竞争格局也随之重塑。随着临床医生和患者越来越重视眼表健康和累积防腐剂暴露，无防腐剂技术和一次性使用产品已从利基市场走向主流市场。这种转变推动了对多用途无防腐剂系统和单剂量便利产品的投资，要求製造商采用新的填充技术和品质系统来维持产品的无菌性和稳定性。

评估 2025 年美国关税调整对眼科润滑剂生产和分销的累积营运、采购和策略影响。

政策变化和贸易行动会影响原料和成品的流通，进而对眼科润滑剂製造商的生产决策、定价策略和供应商多元化产生连锁反应。美国2025年实施的关税或贸易分类调整迫使许多製造商和经销商重新评估其采购区域、重新分配库存缓衝，并检验其产品线的到岸成本敏感度。这些事态发展凸显了双重供应商采购、近岸外包选择以及合约柔软性对于减轻关税波动对营运的影响的重要性。

将产品类型、储存策略、分销管道、剂型、活性成分、适应症和最终用户环境与商业性需求联繫起来的综合細項分析

细緻的市场细分观点揭示了临床需求与产品设计和通路选择之间的交集。产品经理和销售团队必须将产品与明确的配方、储存方法、分销管道、剂型、活性成分、适应症和最终用户需求进行配对。产品类型细分包括凝胶、软膏和溶液。凝胶进一步分为卡波姆凝胶和纤维素凝胶，软膏分为石油基软膏和合成软膏，溶液分为多剂量和单剂量两种剂型。防腐剂体系细分将市场分为无防腐剂和添加防腐剂两种选择。无防腐剂产品进一步分为多剂量无防腐剂系统和单剂量製剂，而添加防腐剂的溶液则根据所添加的防腐剂（例如苯扎氯铵、氯丁醇和硫柳汞）进行分类。

区域趋势和监管差异将影响市场进入和差异化商业策略。

区域趋势交织着监管要​​求、患者行为和分销生态系统，形成复杂的格局，对产品策略和市场推广产生重大影响。在美洲，消费者对眼表疾病的认知度不断提高，强大的零售药房网络推动了对便捷、循证解决方案的需求，而非处方药标籤和产品功效方面的监管规定日益清晰，也为简化商业化路径提供了支持。北美临床医生越来越倾向于使用不含防腐剂的产品进行慢性病管理，促使製造商优先考虑在该地区进行消费者教育和临床医生推广活动。

竞争领导企业如何将配方创新、製造伙伴关係、临床证据和全通路分销策略相结合，从而在眼部润滑剂市场中脱颖而出。

在眼科润滑剂领域，竞争优势越来越依赖配方差异化、卓越的生产製造和成熟的市场推广策略。主要企业正投资研发无防腐剂技术、多剂量无菌给药系统和新型黏度调节剂，以改善临床疗效和提高病患依从性。这些投资辅以扩大的临床计画和真实世界证据研究，以支持产品的安全性和耐受性，尤其是在长期使用者中。成熟品牌与专业契约製造生产商之间正在建立策略联盟，这不仅能加快灌装能力和特种包装的获取，又能有效控制资本密集度。

製造商和经销商的具体策略重点，旨在确保供应弹性、加速推广无防腐剂产品并加强通路特定的商业化。

产业领导者应集中精力增强眼科润滑剂品类的韧性，并挖掘其差异化价值。首先，应优先投资于不含防腐剂的多剂量技术和检验的单剂量系统，以维持供应链效率，同时满足临床医生和患者对长期眼表管理的偏好。其次，应实现关键原材料（包括聚合物、活性成分和一次性包装组件）供应商的多元化，以减轻贸易中断和关税波动的影响，并尽可能与区域製造伙伴关係建立合作关係。

严谨的检验调查方法结合了相关人员访谈、临床和监管分析以及供应链评估，以得出可操作的见解。

本研究采用三角测量法，结合关键相关人员访谈、监管和临床文献综述以及供应链评估，以确保获得可靠且可操作的见解。主要资讯来源包括对临床医生、药剂师、采购负责人和生产合作伙伴的结构化访谈，以收集有关临床偏好、采购动机和营运限制的第一手资讯。次要分析涵盖同侪审查的临床文献、监管指导文件和技术白皮书，以检验製剂趋势、安全性考量和标籤要求。

总之，综合分析表明，配方、监管、通路和供应链要求的整合将决定眼科润滑剂领域的长期成功。

总而言之，非处方眼药水和润滑剂品类正处于一个转折点，配方创新、监管对防腐剂的关注、分销渠道转型以及供应链韧性正在共同决定竞争优势。患者对耐受性良好、疗效显着且易于使用的产品的需求，推动了无防腐剂配方和多种剂型的应用，而临床医生则继续透过实证医学建议影响产品选择。同时，关税和贸易波动凸显了策略采购和区域生产模式对于维持供应连续性和控製成本的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 非处方眼药水和润滑剂市场（依产品类型划分）

  • 凝胶
    • 卡波姆凝胶
    • 纤维素凝胶
  • 软膏
    • 石油基
    • 合成碱
  • 解决方案
    • 多剂量溶液
    • 单剂量溶液

9. 非处方眼药水和润滑剂市场依储存方式划分

  • 未添加防腐剂
    • 不添加防腐剂
    • 单剂量型
  • 含防腐剂
    • 苯扎氯铵
    • 氯丁醇
    • 硫柳汞

10. 非处方眼药水和润滑剂市场按剂型划分

  • 多用途型
    • 瓶子
    • 喷
  • 一次使用
    • 安瓿
    • 最低

11. 非处方眼药水和润滑剂市场（依活性成分划分）

  • 羧甲基纤维素
  • 玻尿酸
  • 聚乙二醇

12. 非处方眼药水和润滑剂市场依适应症划分

  • 缓解过敏症状
  • 干眼症
  • 缓解血液淤血

13. 非处方眼药水和润滑剂市场依分销管道划分

  • 医院药房
  • 网路药房
  • 零售药房

14. 非处方眼药水和润滑剂市场（依最终用户划分）

  • 诊所
  • 居家照护
  • 医院

15. 非处方眼药水和润滑剂市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

16. 非处方眼药水和润滑剂市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各国非处方眼药水及润滑剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国非处方眼药水和润滑剂市场

第十九章 中国非处方眼药水和润滑剂市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AbbVie Inc.
  • AFT Pharmaceuticals Ltd.
  • Alcon Inc.
  • Bausch & Lomb Incorporated
  • Johnson & Johnson Vision
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Rohto Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Similasan AG
  • Sun Pharmaceutical Industries Ltd.
  • Thea SA
  • Ursapharm Arzneimittel GmbH
Product Code: MRR-AE420CB153FD

The OTC Eye Drops & Lubricants Drugs Market was valued at USD 23.40 billion in 2025 and is projected to grow to USD 25.08 billion in 2026, with a CAGR of 7.23%, reaching USD 38.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 23.40 billion
Estimated Year [2026] USD 25.08 billion
Forecast Year [2032] USD 38.17 billion
CAGR (%) 7.23%

A succinct and authoritative introduction framing the clinical, commercial, and consumer trends that are redefining OTC eye drops and ocular lubricant strategies

The over-the-counter eye drops and ocular lubricants category occupies a critical intersection of consumer health, ophthalmology practice, and retail pharmacy channels, driven by rising symptomatic presentations, heightened patient awareness, and product innovation. Chronic ocular surface conditions and episodic irritations have elevated demand for accessible treatments that balance efficacy, tolerability, and convenience. Concurrently, advancements in formulation science and preservative technology have shifted expectations toward gentler, longer-lasting relief options, prompting manufacturers to reassess portfolio strategies and manufacturing investments.

Patients and caregivers increasingly approach ocular care as part of routine wellness rather than episodic intervention, influencing purchase patterns across clinics, hospitals, and retail environments. Digital information channels and direct-to-consumer education are amplifying product differentiation, while healthcare practitioners play a pivotal role in guiding selection between gels, ointments, and solution formats. In this environment, successful players prioritize a deep understanding of usage contexts, such as single-use versus multi-use dosing or targeted active ingredients, and align messaging to clinical evidence and practical benefits. The interplay of regulatory attention on preservatives, logistical realities of global supply chains, and shifting distribution models creates both complexity and opportunity for stakeholders seeking durable market positions.

How formulation breakthroughs, preservative scrutiny, and channel evolution are driving a structural transformation across OTC ocular lubricant development and commercialization

Over the past several years, transformative shifts in the ocular lubricants landscape have accelerated as formulation science, distribution channels, and regulatory scrutiny converge to reshape competitive dynamics. Preservation-free technologies and single-use formats have moved from niche to mainstream as clinicians and patients emphasize ocular surface health and cumulative preservative exposure. This shift has catalyzed investment in multi-dose preservative-free systems and unit-dose convenience options, requiring manufacturers to adopt new filling technologies and quality systems to maintain sterility and shelf stability.

Simultaneously, retail and online pharmacy channels are recalibrating how consumers discover and procure ocular care products. Evolving e-commerce capabilities, subscription models, and telehealth triaging are reducing friction for repeat purchase and heightening the importance of digital product education. On the regulatory front, heightened attention to preservatives such as benzalkonium chloride has encouraged clear labeling strategies and evidence generation to support safety claims. Finally, sustainability expectations and packaging innovation are influencing formulation decisions and cost structures, with many organizations integrating lifecycle thinking into product design and supply chain planning. Together, these shifts are creating a landscape where agility, scientific credibility, and channel-specific strategies determine long-term viability.

Assessing the cumulative operational, sourcing, and strategic ramifications of United States tariff adjustments in 2025 on the production and distribution of ocular lubricants

Policy changes and trade measures affecting raw material and finished product flows can have a cascading influence on manufacturing decisions, pricing strategies, and supplier diversity for ocular lubricant producers. Adjustments to tariffs or trade classifications in the United States during 2025 have prompted many manufacturers and distributors to reassess sourcing geographies, reallocate inventory buffers, and examine landed cost sensitivities across product families. These dynamics have emphasized the importance of supplier dual-sourcing, nearshoring options, and contractual flexibility to mitigate the operational impacts of tariff volatility.

Beyond direct cost implications, tariff-driven shifts have accelerated strategic reconsideration of production footprints, with some organizations exploring regional manufacturing partnerships to shorten supply chains and secure critical inputs such as polymers, high-purity actives, and single-use packaging components. The cumulative effect has been a renewed focus on supply chain transparency and scenario planning, enabling organizations to preserve product continuity and manage commercial expectations with trade partners and customers. Importantly, decision-makers are prioritizing investments that reduce exposure to single points of failure while ensuring regulatory compliance and maintaining product performance characteristics that consumers and clinicians expect.

Comprehensive segmentation insights linking product types, preservation strategies, distribution channels, dosage forms, actives, indications, and end-user contexts to commercial imperatives

A nuanced segmentation view reveals where clinical needs intersect with design and channel choices, and it is essential for product managers and commercial teams to map offerings against distinct formulation, preservation, distribution, dosage, active-ingredient, indication, and end-user requirements. Product type segmentation encompasses gels, ointments, and solutions, with gels further differentiated into carbomer gels and cellulose-based gels, ointments separated into petroleum-based and synthetic-based variants, and solutions split into multi-dose and single-dose formats. Preservation system segmentation divides the market between preservative-free and preserved options, where preservative-free offerings are further characterized as multi-dose preservative-free systems and unit-dose presentations, and preserved solutions are parsed by agents such as benzalkonium chloride, chlorobutanol, and thimerosal.

Distribution channel segmentation captures hospital pharmacy, online pharmacy, and retail pharmacy pathways, each of which demands distinct packaging, labeling, and marketing approaches. Dosage form considerations distinguish multi-use delivery systems, typified by bottles and spray formats, from single-use presentations delivered in ampoules and minims, with implications for user convenience and contamination risk. Active ingredient segmentation highlights common agents such as carboxymethylcellulose, hyaluronic acid, and polyethylene glycol, each with different viscosity, retention, and patient tolerability profiles. Indication-based segmentation shows clear separation among allergy relief, dry eye, and redness relief use cases, guiding claim frameworks and clinical evidence requirements. Finally, end-user segmentation identifies clinics, homecare settings, and hospitals as primary channels for use and procurement, thereby shaping sampling strategies, clinician engagement programs, and bulk purchasing considerations. Integrating these segments into product roadmaps and go-to-market plans enables precise targeting of unmet needs while aligning regulatory, manufacturing, and commercial capabilities.

Regional dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape differentiated market access and commercial approaches

Regional dynamics create a mosaic of regulatory expectations, patient behaviors, and distribution ecosystems that materially influence product strategy and market access. In the Americas, consumer awareness of ocular surface disease and strong retail pharmacy networks drive demand for accessible, evidence-based solutions, while regulatory clarity around OTC labeling and product claims supports straightforward commercialization pathways. North American clinicians increasingly favor preservative-free options for chronic management, prompting manufacturers to prioritize consumer education and clinician outreach within this region.

Across Europe, Middle East & Africa, regulatory diversity and healthcare delivery variability require tailored approaches to registration, pricing, and distribution. Some markets in this region demonstrate rigorous scrutiny of preservative content and require localized clinical justification for novel delivery systems, while other territories prioritize cost-effective supply and established brand trust. Asia-Pacific presents a heterogeneous landscape characterized by rapid digital adoption, high sensitivity to convenience and branding, and strong growth in online pharmacy channels. Local manufacturing partnerships and regulatory agility are often decisive in navigating import requirements and meeting consumer expectations for premium actives such as hyaluronic acid. Recognizing these regional differences enables product teams to sequence market entries, adapt packaging and claims, and coordinate supply chain investments that align with local regulatory and commercial realities.

How competitive leaders are combining formulation innovation, manufacturing partnerships, clinical evidence, and omnichannel commercialization to differentiate in ocular lubricant markets

Competitive positioning in the ocular lubricants space increasingly depends on a combination of formulation differentiation, manufacturing excellence, and go-to-market sophistication. Leading companies are investing in preservative-free technologies, multi-dose sterile delivery systems, and novel viscosity modifiers to enhance clinical outcomes and patient adherence. These investments are complemented by expanded clinical programs and real-world evidence initiatives that underscore product safety and comparative tolerability, particularly for long-term users. Strategic partnerships between established brands and specialist contract manufacturers have emerged to accelerate access to filling capabilities and specialized packaging while managing capital intensity.

Marketing and distribution strategies are evolving as well, with market leaders allocating resources to omnichannel engagement, targeted clinician education, and patient support programs that drive trial and retention. Supply chain resilience is a competitive lever, and organizations that demonstrate robust supplier diversification, quality systems, and contingency planning can better navigate raw material fluctuations and regulatory inspections. Finally, smaller disruptors and private label entrants are focusing on niche indications, value propositions, or sustainability narratives to capture specific consumer cohorts, prompting incumbents to refine segmentation and loyalty strategies to protect core revenues and margin profiles.

Actionable strategic priorities for manufacturers and distributors to secure supply resilience, accelerate preservative-free adoption, and strengthen channel-specific commercialization

Industry leaders should pursue a focused set of actions to strengthen resilience and capture differentiated value in the ocular lubricants category. First, prioritize investment in preservative-free multi-dose technologies and validated unit-dose systems to meet clinician and patient preferences for long-term ocular surface management while preserving supply chain efficiency. Second, diversify supplier bases for critical inputs such as polymers, actives, and single-use packaging components to reduce exposure to trade disruptions and tariff volatility, and supplement this with regional manufacturing partnerships where feasible.

Third, accelerate evidence generation around tolerability and real-world performance for key active ingredients like hyaluronic acid, carboxymethylcellulose, and polyethylene glycol to underpin claims and clinician confidence. Fourth, tailor channel strategies to the distinct needs of hospital pharmacies, online pharmacies, and retail pharmacies by optimizing packaging, sample programs, and digital content for each distribution pathway. Fifth, embed sustainability and lifecycle considerations into packaging design and procurement decisions to meet stakeholder expectations and potentially lower long-term costs. Taken together, these actions create a pragmatic roadmap for balancing short-term operational stability with long-term differentiation and patient-centric innovation.

A rigorous triangulated research methodology combining stakeholder interviews, clinical and regulatory analysis, and supply chain assessment to produce actionable insights

This research employs a triangulated methodology combining primary stakeholder interviews, regulatory and clinical literature review, and supply chain assessment to ensure robust, actionable insights. Primary inputs include structured interviews with clinicians, pharmacists, procurement officers, and manufacturing partners to capture first-hand perspectives on clinical preferences, purchasing drivers, and operational constraints. Secondary analysis encompasses peer-reviewed clinical literature, regulatory guidance documents, and technical white papers to validate formulation trends, safety considerations, and labeling requirements.

Supply chain evaluation integrates supplier mapping, raw material origin analysis, and packaging ecosystem appraisal to identify potential risk concentrations and mitigation pathways. Synthesis of these data streams is iterative: initial findings are validated through expert consultations and scenario testing, and conclusions are refined to reflect practical feasibility and regulatory constraints. The methodology emphasizes transparency in source attribution and encourages ongoing calibration as new regulatory changes, clinical evidence, or trade policies emerge, ensuring recommendations remain relevant for decision-makers seeking to operationalize insights.

Concluding synthesis emphasizing the convergence of formulation, regulatory, channel, and supply chain imperatives that will determine long-term success in the ocular lubricants category

In summary, the over-the-counter eye drops and ocular lubricants category is at an inflection point where formulation innovation, regulatory attention to preservatives, channel transformation, and supply chain resilience converge to define competitive advantage. Patient expectations for tolerable, effective, and convenient solutions are driving adoption of preservative-free systems and diverse dosage forms, while clinicians continue to influence product selection through evidence-based recommendations. At the same time, tariff and trade dynamics underscore the importance of strategic sourcing and regional manufacturing options to sustain continuity and manage costs.

For executives and product teams, the path forward requires integrated planning that aligns R&D priorities with manufacturing capabilities and channel strategies. Investing in real-world evidence, diversifying suppliers, and tailoring messaging for distinct distribution channels will enable organizations to meet evolving clinical needs and consumer preferences. Ultimately, those that combine scientific rigor with operational agility and targeted commercialization will be best positioned to deliver meaningful benefits to patients while achieving durable business outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. OTC Eye Drops & Lubricants Drugs Market, by Product Type

  • 8.1. Gels
    • 8.1.1. Carbomer Gels
    • 8.1.2. Cellulose Based Gels
  • 8.2. Ointments
    • 8.2.1. Petroleum Based
    • 8.2.2. Synthetic Based
  • 8.3. Solutions
    • 8.3.1. Multi Dose Solutions
    • 8.3.2. Single Dose Solutions

9. OTC Eye Drops & Lubricants Drugs Market, by Preservation System

  • 9.1. Preservative Free
    • 9.1.1. Multi Dose Preservative Free
    • 9.1.2. Unit Dose
  • 9.2. Preserved
    • 9.2.1. Benzalkonium Chloride
    • 9.2.2. Chlorobutanol
    • 9.2.3. Thimerosal

10. OTC Eye Drops & Lubricants Drugs Market, by Dosage Form

  • 10.1. Multi Use
    • 10.1.1. Bottles
    • 10.1.2. Spray
  • 10.2. Single Use
    • 10.2.1. Ampoules
    • 10.2.2. Minims

11. OTC Eye Drops & Lubricants Drugs Market, by Active Ingredient

  • 11.1. Carboxymethylcellulose
  • 11.2. Hyaluronic Acid
  • 11.3. Polyethylene Glycol

12. OTC Eye Drops & Lubricants Drugs Market, by Indication

  • 12.1. Allergy Relief
  • 12.2. Dry Eye
  • 12.3. Redness Relief

13. OTC Eye Drops & Lubricants Drugs Market, by Distribution Channel

  • 13.1. Hospital Pharmacy
  • 13.2. Online Pharmacy
  • 13.3. Retail Pharmacy

14. OTC Eye Drops & Lubricants Drugs Market, by End User

  • 14.1. Clinics
  • 14.2. Homecare
  • 14.3. Hospitals

15. OTC Eye Drops & Lubricants Drugs Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. OTC Eye Drops & Lubricants Drugs Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. OTC Eye Drops & Lubricants Drugs Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States OTC Eye Drops & Lubricants Drugs Market

19. China OTC Eye Drops & Lubricants Drugs Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AbbVie Inc.
  • 20.6. AFT Pharmaceuticals Ltd.
  • 20.7. Alcon Inc.
  • 20.8. Bausch & Lomb Incorporated
  • 20.9. Johnson & Johnson Vision
  • 20.10. Novartis AG
  • 20.11. Otsuka Pharmaceutical Co., Ltd.
  • 20.12. Pfizer Inc.
  • 20.13. Prestige Consumer Healthcare Inc.
  • 20.14. Rohto Pharmaceutical Co., Ltd.
  • 20.15. Santen Pharmaceutical Co., Ltd.
  • 20.16. Similasan AG
  • 20.17. Sun Pharmaceutical Industries Ltd.
  • 20.18. Thea S.A.
  • 20.19. Ursapharm Arzneimittel GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CARBOMER GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CARBOMER GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CARBOMER GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CELLULOSE BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CELLULOSE BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CELLULOSE BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PETROLEUM BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PETROLEUM BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PETROLEUM BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SYNTHETIC BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SYNTHETIC BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SYNTHETIC BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI DOSE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI DOSE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI DOSE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE DOSE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE DOSE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE DOSE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI DOSE PRESERVATIVE FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI DOSE PRESERVATIVE FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI DOSE PRESERVATIVE FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY UNIT DOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY UNIT DOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY UNIT DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CHLOROBUTANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CHLOROBUTANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CHLOROBUTANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY THIMEROSAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY THIMEROSAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY THIMEROSAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY AMPOULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MINIMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MINIMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MINIMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ALLERGY RELIEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ALLERGY RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DRY EYE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DRY EYE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DRY EYE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY REDNESS RELIEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY REDNESS RELIEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY REDNESS RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 261. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 263. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 264. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 265. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 267. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 268. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. GCC OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVATIVE FREE, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY PRESERVED, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY MULTI USE, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS OTC EYE DROPS & LUBRICANTS DRUGS MARKET SIZE, BY SINGLE USE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS OTC EYE DROPS & LUBRICAN